Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GreenMart is a vertically integrated medical cannabis company that operates as a key subsidiary of iAnthus Capital Holdings. The company specializes in the cultivation, production, and wholesale distribution of high-quality medical cannabis products, including flower and high-margin concentrates under the Melting Point Extracts (MPX) brand. GreenMart maintains a significant presence in the Nevada and Maryland markets, where it provides pharmaceutical-grade cannabinoid therapies for patients with chronic conditions such as epilepsy and severe pain. By leveraging advanced extraction technologies and standardized cultivation protocols, the company ensures consistent therapeutic profiles across its product lines. GreenMart's operations are integrated into the broader iAnthus network, which focuses on expanding patient access to regulated cannabis-based healthcare solutions in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GreenMart.